𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Caspofungin + liposomal amphotericin B for kids with refractory aspergillosis?

Book ID
120858369
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liposomal amphotericin B in combination
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies : A randomized pilot study (Combistrat trial)
✍ Denis Caillot; Anne ThiΓ©baut; Raoul Herbrecht; StΓ©phane de Botton; Arnaud Pigneu πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a

Amphotericin B lipid complex versus lipo
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
✍ Ray Y. Hachem; Maha R. Boktour; Hend A. Hanna; Rola N. Husni; Harrys A. Torres; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancy (HM). There are 2 lipid formulations of amphotericin B (AMB) currently in widespread use: AMB lipid complex (ABLC) and liposomal AMB (L‐AMB). There are limited